Sun.Dec 08, 2024

article thumbnail

The Big 3 PBMs are Countersuing the FTC. Does Their Argument Have Any Teeth?

MedCity News

After the FTC filed a lawsuit in September, accusing the three major pharmacy benefit managers of anticompetitive rebating practices related to insulin, the defendants reversed roles and became plaintiffs. In November, they countersued the agency, arguing that its lawsuit is unconstitutional. The post The Big 3 PBMs are Countersuing the FTC. Does Their Argument Have Any Teeth?

article thumbnail

A Day in the Life of a Medical Sales Rep in a Multinational Pharma Company

Contrarian Sales Techniques

Whats it really like to work as a medical sales rep for a multinational pharmaceutical company (MNC) in Malaysia? From early morning territory visits to evening follow-ups, its a fast-paced, rewarding career with its fair share of challenges and surprises. If youve ever wondered what goes on behind the scenes, heres a glimpse into a typical day in the life of a medical sales rep in an MNChighlighting the perks, obstacles, and realities of the job. 6:30 AM: Starting the Day Right A medical sales

article thumbnail

Safety Signal in Phase 2 Deals a Setback to BioAge Labs’ Muscle-Preserving Obesity Drug

MedCity News

BioAge Labs said the potential safety problem was observed in some who received experimental drug azelaprag, which is being tested as a monotherapy and in combination with Eli Lilly obesity medication Zepbound. No safety signals were observed in those who received Zepbound alone. The post Safety Signal in Phase 2 Deals a Setback to BioAge Labs Muscle-Preserving Obesity Drug appeared first on MedCity News.

Safety 105
article thumbnail

ASHP: Identify and Counsel Patients at High Risk for Severe COVID-19

Pharmacy Times

By identifying patients at high risk for progressing to severe disease and counseling them on their treatment options, pharmacists empower patients to make informed decisions about their treatment.

article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

Integrating Advanced Technologies for Pharma Analysis

PharmaTech

Automation technologies provide real potential to improve responsiveness and decision-making in drug development.

Pharma 59
article thumbnail

Fixed-Duration Acalabrutinib and Venetoclax Regimens Redefine First-Line Treatment Options for Patients With CLL

Pharmacy Times

The phase 3 AMPLIFY trial demonstrates that fixed-duration regimens of acalabrutinib and venetoclax, with or without obinutuzumab, significantly improve progression-free survival and deliver manageable safety profiles compared to chemoimmunotherapy in treatment-naive chronic lymphocytic leukemia (CLL).

Safety 57

More Trending

article thumbnail

ASHP Midyear: Opioid Use Disorder in Critically Ill Patients Has Unique Challenges

Pharmacy Times

In hospital and critical care settings, pharmacists can play a significant role in educating other health care providers about treatment options, proper dosing, and more.

article thumbnail

Endometriosis: The Complex, Whole-body Disease We Need to be Talking About

MedCity News

Through the years, Ive seen 12 different GI specialists, countless gynecologists, and many other specialists. Ive had at least 10 surgeries and procedures. Here are three ways to prevent your patients from going through the same thing. The post Endometriosis: The Complex, Whole-body Disease We Need to be Talking About appeared first on MedCity News.

Patients 119
article thumbnail

ASH 2024: Rapid Uptake of Bispecific Antibodies for R/R Multiple Myeloma Observed in Community Oncology Settings

Pharmacy Times

Ira Zackon, MD explains his analysis of bispecific antibody utilizaton for relapsed or refractory multiple myeloma in community oncology centers.

54
article thumbnail

More than a Third of the US has Dental Anxiety. Here’s How New Technology is Improving Patient Trust

MedCity News

The integration of the latest technologies improves diagnostic quality and accelerates treatment solutions, decreasing the time patients spend in discomfort or pain due to dental issues. The post More than a Third of the US has Dental Anxiety. Heres How New Technology is Improving Patient Trust appeared first on MedCity News.

Patients 105
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

ASHP Midyear: Pharmacists Play Key Role in Optimizing Continuous Glucose Monitoring for Diabetes Management

Pharmacy Times

Pharmacists can leverage continuous glucose monitoring data to personalize diabetes management, overcome clinical inertia, and improve glycemic control for patients.

article thumbnail

ASH: Zanubrutinib Demonstrates Long-Term Efficacy in Patients With Waldenström Macroglobulinemia

Pharmacy Times

Shirley D'Sa, MD, highlights the long-term efficacy and tolerability of zanubrutinib in patients with Waldenstrm macroglobulinemia, as seen in the long-term extension of ASPEN.

article thumbnail

ASH 2024: New Treatments in Trial Pipeline Show Promising Survival Rates in R/R Multiple Myeloma

Pharmacy Times

Robert Rifkin, MD, FACP, discusses multiple abstracts featuring drugs demonstrating efficacy in patients with relapsed/refractory multiple myeloma.

article thumbnail

Daratumumab Demonstrates Significant Benefit in High-Risk Smoldering Myeloma: Results from the Phase 3 AQUILA Study

Pharmacy Times

The AQUILA study demonstrates that early treatment with daratumumab significantly delays progression to symptomatic multiple myeloma, improves survival outcomes, and offers a well-tolerated alternative to traditional observation.

45
article thumbnail

10 Ways to Leverage Buyer Signals and Drive Revenue

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

article thumbnail

ASHP Midyear: Expert Highlights New Non-Statin Medication and Combination Therapy Strategies

Pharmacy Times

Both statins and newer non-statin medications are important in combination to effectively lower atherogenic lipid levels and reduce cardiovascular risk.

Medical 26